|
It was reported retracta detachable embolization coil was used in a (b)(6) female during an embolization procedure to treat varicose veins in the pelvis.As reported, the ¿delivery wire¿ separated from the junction zone and coil in the patient.The embolization coil appeared to separate from the junction zone as intended.The physician retracted the delivery wire, experienced some resistance and the delivery wire separated.As reported the physician attempted to remove unintended device segment with an unknown snare device, however was unsuccessful.Physician continued the procedure and placed additional coils (as intended), and stated these additional coils will help secure the device segment from potential migration.No other adverse effects were reported for this incident.Additional information regarding the event and patient outcome has been requested but is currently unavailable.
|
|
D10 ¿ product received on: 01apr2019.Investigation ¿ evaluation.A review of the complaint history, device history record, drawing, instructions for use (ifu), manufacturing instructions, and quality control of the device, as well as a visual inspection and dimensional verification, were conducted during the investigation.The delivery wire and separated pieces of the embolization coil were returned.The visual inspection fount the end coil of the delivery wire was severely damaged.The pieces of the embolization coil could not be analyzed.Dimensional analysis could not be completed due to the received condition of the delivery wire and embolization coil.The complaint was confirmed based on the customer testimony and evaluation of the returned device.Additionally, a document based investigation evaluation was performed.There is no evidence to suggest the product was not made to specifications.A review of the device history record showed no nonconforming events which could contribute to this failure mode.It should be noted there were no other reported complaints for this lot number.Based on the information provided, the device evaluation and the results of the investigation, it was concluded a random component failure could have contributed to this failure.The appropriate personnel have been notified.Per the quality engineering risk assessment no further action is required.Cook will continue to monitor for similar complaints.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|